Evidence map›Paper›PMID 16010455›Full record

ArticlePituitary2004

Non-functioning pituitary carcinoma.

Petra Nadja Elsässer Imboden, François-Xavier Borruat, Nicolas De Tribolet, Kathleen Meagher-Villemure, Alesia Pica, Fulgencio Gomez

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pituitary, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Pituitary carcinoma with intraspinal metastasis: report of two cases and review of the literature.International journal of clinical and experimental pathology · 2015
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Petra Nadja Elsässer ImbodenService of Endocrinology, Diabetology and Metabolism, Department of Internal Medicine, University Hospital, Lausanne, Switzerland.
François-Xavier BorruatDepartment of Ophthalmology, Hôpital Ophtalmique Jules-Gonin, Lausanne, Switzerland.
Nicolas De TriboletDepartment of Neurosurgery, University Hospital, Lausanne, Switzerland.
Kathleen Meagher-VillemureDepartment of Pathology, University Hospital, Lausanne, Switzerland.
Alesia PicaService of Radio-Oncology, University Hospital, Lausanne, Switzerland.
Fulgencio GomezService of Endocrinology, Diabetology and Metabolism, Department of Internal Medicine, University Hospital, Lausanne, Switzerland. Fulgencio.Gomez@chuv.hospvd.ch.
Hôpital Ophtalmique Jules-Gonin · CHUniversity Hospital of Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Null-cell carcinomas of the pituitary are extremely rare. We describe a 41-year-old woman with a large adenohypophyseal neoplasm presenting as a primary nonfunctioning tumor without pituitary insufficiency. Signs of mass effect with progressive unilateral ocular motility disorders and anterior pituitary failure developed rapidly. Histopathological examination of the trans-sphenoidally removed tumor showed a primary pituitary null cell tumor with high mitotic index. Pituitary carcinoma was suspected because of rapid relapse of ocular motility disorders and of intra-sellar tumor growth after surgery. Radiotherapy of the sellar and parasellar area with a total dose of 59.4 Gy was performed, achieving marked tumor reduction and a significant improvement of ocular motility disorders. However, 6.5 months after presentation the patient rapidly declined and died of carcinomatous meningitis. Less than 100 pituitary carcinomas have been published so far, most of them as single-case reports, and endocrine, immunohistochemical, and ultrastructural data have not been described in the majority of cases. At presentation, there are no specific symptoms that allow to distinguish benign from malignant tumor. Prognosis is poor, since no curative treatment has been established, but aggressive surgery and radiotherapy has been recommended. Our case highlights the poor prognosis of nonfunctioning pituitary carcinomas.

Indexed as

AdultCombined Modality TherapyFatal OutcomeFemaleHumansHypopituitarismImmunohistochemistryMagnetic Resonance ImagingMeningitisOcular Motility DisordersPituitary Gland, AnteriorPituitary Hormones, AnteriorPituitary NeoplasmsRadiotherapyPituitary Hormones, Anterior

Identifiers

PMID16010455
OpenAlexW1990717449

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.